newsfilter
← Latest News
Business Wire·

Newman Ferrara LLP Announces Investigation of Furiex Pharmaceuticals, Inc.

NEW YORK--(BUSINESS WIRE)--Newman Ferrara LLP is investigating potential claims against the board of directors of Furiex Pharmaceuticals, Inc. (“Furiex”) (Nasdaq:FURX) concerning the proposed sale of Furiex to Forest Laboratories Inc. (“Forest”) (NYSE:FRX).